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ABSTRACT
Background – Thymic stromal lymphopoietin (TSLP) plays a key role in the development of allergic inflamma-
tion. Little is known about possible triggers of equine TSLP expression.
Hypothesis/objectives – To investigate TSLP expression in equine insect bite hypersensitivity (IBH) skin lesions.
The capacity of TLR 1-8 ligands (L) and of atopic cytokine milieu as potential triggers of TSLP and of interleukin (IL)-
6 as a downstream effector molecule of TLR signalling, were examined in primary equine keratinocyte cultures.
Animals – Lesional skin from IBH-affected and healthy skin from control-horses (n = 9 each group) was sampled.
Methods and materials – Keratinocyte cultures were established from six healthy horses and stimulated with
TLR 1-8-L, and with IL-4 and tumor necrosis factor-a, to mimic an atopic inflammation cytokine milieu. TSLP and
IL-6 gene expression was assessed by quantitative real-time PCR.
Results – Expression of TSLP was significantly greater in IBH lesions compared to healthy skin. TLR 1-8-L signifi-
cantly upregulated TSLP expression in keratinocytes. The strongest upregulation was induced by TLR 1/2-L and
TLR 3-L. Combination of atopic cytokine milieu and TLR 1/2-L or TLR 3-L further increased TSLP expression. TLR-
L 1-5 stimulation significantly upregulated IL-6 expression.
Conclusions and clinical importance – The data herein suggest that the upregulation of TSLP expression in
lesional skin of IBH-affected horses might play a role in IBH development. Moreover, TSLP expression is induced
by TLR-L, in particular by TLR 1/2-L and TLR 3-L, and is further increased by atopic cytokine milieu, indicating a
mechanism for TSLP-mediated exacerbation of IBH.
Introduction
Thymic stromal lymphopoietin (TSLP) is an interleukin
(IL)-7 like cytokine that plays a central role in TH-2 cell dif-
ferentiation and development of allergic inflammation.1
Many cell types produce TSLP including epithelial, mast
cells and dendritic cells (DCs), as well as cancer and can-
cer-associated cells.2
TSLP-treated DCs induce a strong proliferation of na€ıve
T cells. In addition, under the influence of TSLP, DCs
secrete TH2-recruiting chemokines, and induce na€ıve T-
cell differentiation into “inflammatory” TH-2 cells, which
in turn produce IL-4, IL-5 and IL-13, and tumor necrosis
factor (TNF)-a through the OX40 ligand.3 Moreover, TSLP
does not induce the expression of IL-12 or type I
interferons, which would drive the induction of TH-1 dif-
ferentiation,4 thus further skewing the immune response
towards a TH-2 phenotype. Furthermore, TSLP activates
Langerhans cells.5 In combination with IL-1 and TNF-a,
TSLP can act directly on human mast cells that in turn pro-
duce IL-5 and IL-13. It also can act on human eosinophils
inducing their prolonged survival and secretion of pro-in-
flammatory molecules.6
TSLP is highly expressed in lesional keratinocytes of
humans affected by atopic dermatitis (AD), where it plays
a central role in triggering allergic diseases.4 Ker-
atinocytes are the predominant cell type in the epidermis,
forming the physical barrier to the external environment.7
Besides this role, keratinocytes also produce several
cytokines and chemokines that ultimately shape the
immune response. For example, in response to external
stimuli, human keratinocytes produce cytokines such as
IL-25, IL-33 and TSLP.7 The production of TSLP by ker-
atinocytes, together with its functional ability to skew the
immune response towards TH-2 subtype, makes TSLP a
critical factor linking responses at the interface between
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the body and the external environment to TH-2 pheno-
type.8
Information on the environmental and endogenous trig-
gers of TSLP expression, which is essential to elucidate
the underlying mechanisms of allergic diseases, is still
limited. Bogiatzi et al. have shown that pro-inflammatory
and TH-2 cytokines act synergistically to induce TSLP
expression in skin explants from healthy donors.9
In horses, keratinocytes and TSLP have not been studied
extensively and little is known about their possible role in
the development of allergic diseases such as insect bite
hypersensitivity (IBH). IBH is an IgE-mediated, type I hyper-
sensitivity caused by bites of insects in the genus Culi-
coides, and clinically is seen as a recurrent dermatitis in
horses.10 Although the possible role of TSLP in IBH devel-
opment is unknown, one study reported the generation of
equine TSLP-specific antibodies and showed that TSLP
production was induced in equine primary keratinocytes by
stimulation with whole-body extract of Culicoides midges,
whose salivary gland proteins are causative allergens of
equine IBH.11 However, keratinocytes from only one
healthy horse was used in that study. Another study
reported TSLP upregulation in bronchial alveolar lavage
cells derived from horses affected by equine asthma (RAO)
and in bronchial epithelial cells (BAC) after stimulation with
hay dust extract in vitro.12 Possible endogenous or exoge-
nous triggers of equine TSLP expression in homeostasis or
disease state remain to be elucidated.
Based on the demonstration that TSLP is the linking
factor between the environmental stimuli and the type of
immune response, it is hypothesized herein that the
expression of equine TSLP is upregulated in primary
equine keratinocytes by Toll-like receptor (TLR) ligands
(TLR-L). TLRs are pattern recognition receptors that rec-
ognize pathogen-associated molecular patterns (PAMPs)
on various microbes and therefore play an essential func-
tion in innate immunity.13 Binding of ligands to TLRs leads
to the activation of several signalling pathways, including
NF-jB and MAP (mitogen-activated protein) kinases that
in turn induce the expression of various genes involved in
host defence, such as IL-6 and IL-1, chemokines, major
histocompatibility complex (MHC) and co-stimulatory
molecules. In one study, equine keratinocytes responded
to stimulation with LPS (TLR-4 ligand) and flagellin (TLR-5
ligand) by increased expression of inflammatory cytokine
genes, suggesting that equine keratinocytes express
functional TLR-4 and TLR-5.14
The primary aim of this study was to investigate
whether equine TSLP is differentially expressed in
lesional skin of IBH-affected horses compared to the skin
of healthy horses. A further aim was to examine in pri-
mary equine keratinocytes the capacity of TLR 1-8-L to
induce the expression of TSLP and the pro-inflammatory
cytokine IL-6, as a downstream effector molecule of TLR
signalling. For comparison, the TLR-L-induced TSLP and
IL-6 expression in peripheral blood mononuclear cells
were examined. Finally, it was investigated whether aller-
gic inflammation cytokine milieu (IL-4 and TNF-a) induces
TSLP expression in keratinocytes from nonallergic horses
and acts synergistically with TLR-1/2 and TLR-3-induced
TSLP expression.
Methods and materials
Sample collection
This study was approved by the Animal Experimental Committee of
the Canton of Berne, Switzerland (nos BE 2/17 and BE 69/18).
Nine skin biopsies from IBH-affected and nine skin samples from
control horses were taken from the neck or midline area. Biopsies
were collected from slaughtered horses or from IBH-affected horses.
Subsequently, the biopsies were bisected and submerged in RNAla-
ter (Thermo Fisher Scientific; Waltham, MA, USA) and stored at –
80°C until further processing. Blood for isolation of peripheral blood
mononuclear cells (PBMCs) was collected from three nonallergic
horses.
Isolation and culture of primary equine keratinocytes
Primary equine keratinocytes were isolated from skin samples
obtained from six slaughtered horses with no apparent skin disease.
The cells were cultured using a modification of protocols described pre-
viously.11,15 Briefly, skin samples were incubated at 4°C for 24h with
10 mg/mL Dispase II (Roche; Basel, Switzerland) in Williams E med-
ium (Bioconcept; Allschwil, Switzerland). Subsequently, epidermis was
separated from the dermis using sterile forceps and further digested
for 20 min in accutase (CELLnTEC; Bern, Switzerland) in order to pro-
duce single-cell suspensions. Once acquired, keratinocytes were
seeded at 12 x 103 cells per cm2 of cell culture flask and grown in Wil-
liams E medium supplemented with 10% fetal bovine serum (Merck;
Kenilworth, NJ, USA), 10 ng/mL human epidermal growth factor
(Sigma Aldrich; St Louis, MO, USA), 2 mM glutamine, 50 U/mL peni-
cillin, 50 mg/mL streptomycin and amphotericin B (Bioconcept). Cells
were grown in 75 cm2 flasks at a density of 9 x 105 cells per flask and
grown at 35°C, 5% CO2 until they reached 90% confluence. Cells from
passage three were used for stimulation experiments.
Isolation of peripheral blood mononuclear cells
Blood from three nonallergic horses was collected from the jugular
vein using sodium heparin-containing vacutainers (Vacuette, Greiner;
St Gallen, Switzerland). Blood was transferred immediately to the lab-
oratory where PBMCs were isolated by density gradient centrifuga-
tion over Ficoll-Hypaque in accordance with Hamza et al.16
Immunofluorescence
In order to confirm the presence of primary equine keratinocytes in
the cultures, cells were grown in chambered cell culture slides (Sarst-
edt; N€umbrecht, Germany) until they reached 70% confluence. Sub-
sequently, cells were fixed using 4% paraformaldehyde (Thermo
Fisher Scientific) for 20 min at room temperature. Cells then were
permeabilized using 0.2% Triton (Biorad; Hercules, CA, USA) and
blocked in 10% normal goat serum (AbCam; Cambridge, UK). They
were incubated overnight at 4°C with the following primary antibod-
ies: polyclonal rabbit anti-bovine cytokeratin (Agilent; Santa Clara, CA,
USA) and mouse monoclonal anti-human vimentin (Agilent) at 4°C.
Washing with 0.025% Tween 20 (Sigma Aldrich) and 45 min incuba-
tion at room temperature with the corresponding secondary antibod-
ies, Alexa Flour 647-labelled goat anti-rabbit (Jackson
ImmunoResearch; West Grove, PA, USA) and Alexa Flour 647-la-
belled goat-anti mouse (Invitrogen) followed. Nuclei were counter-
stained with Hoechst (Sigma Aldrich). Cells were imaged using Zeiss
AxioImager Z1 (Carl Zeiss AG; Oberkochen, Germany). The staining
was carried out for all keratinocyte cultures used in this study.
Stimulation of keratinocytes and PBMCs
Primary equine keratinocytes of passage three were seeded in six
well plates at a density of 3 x 105 cells per well and grown at 35°C,
5% CO2 until they reached 90% confluence. For stimulation experi-
ments, cells were cultured in complete Williams E medium.
After isolation, equine PBMCs were cultured in 12 well plates at a
density of 8 x 106 cells per well in RPMI medium.
Primary keratinocytes and PBMCs were cultured in medium only
or with various TLR-L (as summarized in Table 1) for 4 h and 24 h.
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Furthermore, a combination of 50 ng/mL phorbol 12-myristate 13-ac-
etate(PMA) (Sigma Aldrich) and 1 lmol/mL ionomycin (Sigma
Aldrich) or 5 lg/mL Concanavalin A (Sigma Aldrich) were used as
positive controls. Additionally, a combination of 100 ng/mL recombi-
nant equine TNF-a (R&D Systems; Minneapolis, MN, USA) and
100 ng/mL recombinant equine IL-4 (LubioScience; Z€urich, Switzer-
land) was added to primary equine keratinocytes cultured in the pres-
ence or absence of Pam3CSK4 and Poly (I:C).
Isolation of RNA and cDNA synthesis
Total RNA was isolated from cultured keratinocytes using ReliaPrep
RNA Cell miniprep system (Promega; Madison, WI, USA) according
to the manufacturer’s instructions. Total RNA was extracted from
cultured PBMCs using the RNeasy Mini Kit (Qiagen; Hilden, Ger-
many) according to the manufacturer’s instructions. Before RNA
extraction with the RNeasy Mini Kit, cell lysates were loaded onto a
spin column (QIAshredder; Qiagen) and centrifuged at 16,000g for
2 min. Total RNA from lesional skin of IBH-affected (n = 9) and
healthy horses (n = 9) was extracted using the RNeasy Fibrous Tis-
sue Kit (Qiagen).17 Before RNA extraction, skin samples were lysed
using MagNa tissue lyser (Roche) in which samples were homoge-
nized by collision with ceramic beads (Roche) for 45 s at the shaking
speed of 6,500, followed by 2 min cooling on ice. Homogenization
was repeated for another 30 s at the shaking speed of 6,500 and
supernatants were loaded onto a spin column (QIAshredder, Qiagen)
and centrifuged at 16,000g for 2 min (Qiagen).
For all samples, contaminating genomic DNA was removed by on-
column DNase treatment, and RNA was quantified spectrophotomet-
rically at 260 nm (NanoDrop 2000c, Thermo Fischer Scientific; Rein-
ach, Switzerland) and samples were stored at –80°C until use.
Reverse transcription (RT) of total RNA was performed using
GoScript Reverse Transcription Mix (Promega) to generate comple-
mentary DNA (cDNA) that was used as a template for quantitative (q)
RT-PCR. The cDNA synthesis reaction consisted of 500 ng RNA and
10 uL GoScript Reverse Transcription Mix, which contained 4 lL
nuclease-free water, 4 lL GoScript Reaction Buffer and Random Pri-
mer, and 2 lL GoScript Enzyme Mix, in a total reaction volume of
20 lL. RNA samples and the RT mix were incubated at 25°C for
5 min. Reaction continued at 42°C for 1 h and was terminated by
heating at 70°C for 15 min. The cDNA samples were stored at –20°C
until further processing.
qRT-PCR of primary keratinocytes, PBMCs and skin
Expression of TSLP, IL-6 and the housekeeping gene ubiquitin B
(UBB) was quantified using qRT-PCR. TSLP and UBB primer
sequences were applied as previously published and IL-6 primers
were designed using the PRIMER EXPRESS 3.0.1. program and synthe-
sized by Microsynth (Balgach, Switzerland) (Sequences in Table 2).17
The qRT-PCR mixes consisted of: 1 lL cDNA per reaction, GoTaq
Master Mix 2x (Promega), CXR reference dye 100x (Promega, and
100 lM primers. The qRT-PCR reactions were performed in a total
volume of 10 lL and carried out in a 7300 Real-Time PCR System
(Applied Biosystems; Foster City, CA, USA). The UBB and TSLP qRT-
PCR reaction consisted of initial 15 min at 95°C, followed by 45
cycles of denaturation for 15 s at 95°C, annealing for 30 s at 60°C,
elongation for 30 s at 72°C, and a melting curve program of 95°C for
15 s, followed by 30 s at 60°C and 15 s at 95°C.
The IL-6 qRT-PCR reactions consisted of an initial 2 min at 50°C
and denaturation at 95°C for 10 min, followed by 40 cycles of denatu-
ration for 15 s at 95°C, annealing at 60°C for 1 min, and the same
melting curve program as for the UBB and TSLP qRT-PCR reaction.
All reactions were performed in triplicate, and no template and RT-
negative controls were included in each run. Efficiencies of qRT-
PCRs were calculated using a standard curve derived from pool of
cDNA (Table 2). TSLP and IL-6 gene expression in primary equine ker-
atinocytes and PBMCs was quantified using the ΔΔCt method.
Expression of TSLP and IL-6 was normalized to the expression of
UBB and to the nonstimulated control.
In six of nine skin samples from control horses, and two of nine
samples from IBH-affected horses, TSLP expression was below the
detection limit of the assay. A Ct = 40 was attributed to these sam-
ples to allow their inclusion in the statistical analysis. TSLP expres-
sion in skin samples was quantified using the 1/2ΔCt method, as
described in Hamza et al.; 1/2ΔCt expresses the relative quantity of
TSLP mRNA present in the sample compared to the amount of UBB
in the sample.16
Statistical analyses
For statistical analysis, NCSS software [NCSS 12 Statistical Software
(2018) NCSS, LLC; Kaysville, UT, USA, ncss.com/software/ncss] was
used. Because the data were not normally distributed, descriptive
statistics using median and ranges were used. Comparison of TSLP
mRNA expression in lesional IBH skin to its expression in skin from
healthy horses was performed using the Wilcoxon–Mann–Whitney
U-test, as was comparison of cytokine expression between TLR-li-
gand stimulated and unstimulated keratinocytes. Bonferroni correc-
tion for multiple comparisons (cP) was performed manually (P-value x
number of comparisons = cP). On each occasion, P ≤ 0.05 was
regarded as significant.
In order to compare the effect of addition of inflammatory cytokine
milieu on keratinocyte cultures within each culture conditions (i.e.
within each TLR-ligand stimulation or without addition of TLR-ligand),
a paired Wilcoxon signed rank test was performed.
Results
TSLP expression in lesional skin of IBH-affected
horses
The mRNA expression of TSLP was significantly greater
(median = 0.0114, range 0.0006–0.0580, P < 0.05) in
lesional skin of IBH-affected horses compared to the skin
of nonaffected controls (0.0009, 0.0005–0.0203) (Figure 1).
Establishment of primary equine keratinocyte
cultures
Primary equine keratinocytes were morphologically dis-
tinctive in culture as cobble stone-shaped cells with ovoid
nucleus and indistinct borders.15 Morphologically, all of
the cultures herein corresponded to the description of
keratinocytes. In addition, staining of the primary ker-
atinocyte cultures with anti-cytokeratin confirmed that all
of the cultures consisted of keratinocytes (Figure 2a).
Table 1. Toll like receptor ligands used in the study
TLR Name Origin Concentration
TLR 1/2 Pam3CSK4 Synthetic triacylated lipoprotein1 200 ng/ml
TLR 3 Poly (I:C) Synthetic analogue of dsRNA1 5 lg/ml
TLR 4 LPS Lipopolysaccharide from Escherichia coli1 5 lg/ml
TLR 5 Flagellin Flagellin from Salmonella Typhimurium1 200 ng/ml
TLR 7/TLR 8 Resiquimod Imidazolquinolinamines2 5 lg/ml
TLR 9 CpG-ODN (D-SL03) Unmethylated CpG dinucleotides1 5 lg/ml
1Invivogen, San Diego, CA, USA.
2Sigma Aldrich, St. Louis, MO, USA.
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Moreover, no staining was observed with the anti-vi-
mentin antibody, indicating that the cultures were not
contaminated with fibroblasts, which are common in ker-
atinocyte cultures (Figure 2b). When anti-vimentin anti-
body was used on equine fibroblasts as control staining,
positive staining was observed, confirming antibody reac-
tivity on equine fibroblasts (Figure 2c,d).
TLR ligands and TSLP gene expression in primary
equine keratinocyte cultures
It was then investigated whether TLR-1/2, 3, 4, 5, 7 and 8
ligands induce upregulation of TSLP gene expression in
primary equine keratinocyte cultures and, for comparison,
in PBMCs, after 4 h and 24 h stimulation. TLR-L 9 (CpG-
ODN, D-SL03, InvivoGen; San Diego, CA, USA) was used
in pilot experiments on both primary equine keratinocyte
cultures and PBMCs, but as it did not elicit any TSLP
response, it was not included in the main experiments.
A significant upregulation of TSLP gene expression was
observed in primary equine keratinocytes after stimulation
for 4 h with phorbol 12-myristate 13-acetate (PMA)-iono-
mycin as positive control, and all TLR-Ls used in the pre-
sent study (Figure 3a). The strongest TSLP gene
upregulation was induced by PMA-ionomycin (me-
dian = 1321.35) and Pam3CKS4 (231.72), followed by LPS
(8.87), Poly (I:C) (4.98), resiquimod (5.61) and flagellin
(3.03). Interestingly, Pam3CSK4, the ligand that induced
the strongest upregulation of TSLP in keratinocytes (me-
dian = 231.72), only induced a moderate increase of TSLP
expression in PBMC (34.9). Interestingly, PBMC displayed
a stronger TSLP expression compared to keratinocytes
after stimulation with LPS (median = 103.63) and flagellin
(111.27) (see Figure S1a,b in Supporting Information).
After 24 h stimulation of keratinocytes (Figure 3b), the
effect of some stimuli decreased and there was no signif-
icant difference for flagellin and resiquimod compared to
unstimulated cells. TSLP was still significantly upregu-
lated after 24 h by PMA-ionomycin, Pam3CSK4, Poly (I:C)
and LPS. The strongest upregulation of TSLP after 24 h
stimulation was induced by Poly (I:C) (median = 53.13).
PMA-ionomycin (12.68) and Pam3CSK4 (4.25) induced a
significant upregulation of TSLP as well, but to a lower
extent than after 4 h, whereas TSLP expression induced
by Poly (I:C) was 10-fold higher after 24 h compared to
4 h stimulation (Figure 3b). Medians of both TSLP and IL-
6 expression values for all stimulation conditions are
shown in Table S1.
TLR ligands and IL-6 gene expression in primary
equine keratinocytes and PBMCs
In a similar way to TSLP expression, the expression of
the pro-inflammatory cytokine IL-6 was significantly
upregulated in primary equine keratinocytes after 4 h
stimulation with PMA-ionomycin, Pam3CSK4, Poly (I:C),
LPS and flagellin. However, in contrast to TSLP expres-
sion, stimulation with resiquimod did not induce a signifi-
cant IL-6 increased expression. After 4 h stimulation
(Figure 3c), the strongest upregulation of IL-6 in equine
keratinocytes was induced with Pam3CSK4 (me-
dian = 42.00), followed by LPS (13.27), PMA-ionomycin
(7.84) and Poly (I:C) (7.06). After 24 h stimulation (Fig-
ure 3b), similar to TLR-L-induced TSLP expression, the
effect of some TLR-L on IL-6 upregulation decreased. A
significant upregulation of IL-6 after 24 h was induced
only by Poly (I:C) and LPS stimulation. As for TSLP, the
strongest IL-6 response was observed after stimulation
with Poly (I:C) (median = 54.94) (Figure 3d).
In comparison to keratinocytes, IL-6 was upregulated in
PBMCs after 4 h by PMA-ionomycin, Pam3CSK4, LPS,
flagellin and resiquimod, and weakly by Poly (I:C) stimula-
tion (Figure S1c,d). Effects of IL-4 and TNFa with
Pam3CKS4 and Poly (I:C) on TSLP and IL-6 gene expres-
sion in primary equine keratinocytes.
The subtitle was removed from here, which in my opin-
ion makes the part of cytokine milieu less visible. Since
this is quite an interesting part, I would be very grateful if
we could have a subtitle here. Treatment with recombi-
nant equine IL-4 and TNF-a, which mimics an atopic
inflammatory cytokine milieu, significantly upregulated
TSLP gene expression after 4 h and 24 h in primary
equine keratinocytes. Moreover, the combination of
Pam3CKS4 and atopic cytokine milieu had a synergistic
effect on upregulation of TSLP gene expression. Although
Pam3CSK4 alone already induced a strong upregulation
of TSLP, the combination with atopic cytokine milieu fur-
ther increased TSLP expression. Moreover, although the
effect of stimulation with Pam3CSK4 was only strong
after 4 h and dampened after 24 h stimulation, the com-
bination with atopic cytokine milieu significantly
enhanced TSLP expression even after 24 h (Figure 4a,b).
The same effect of atopic cytokine milieu was
observed in combination with Poly (I:C). The synergistic
effect of the milieu and Poly (I:C) on TSLP gene expres-
sion was seen both after 4 h and 24 h stimulation, with
TSLP gene expression significantly enhanced at both time
points, when compared to stimulation with Poly (I:C) only
(Figure 4a,b).
Next, the effect of the atopic cytokine milieu and
Pam3CSK4 or Poly (I:C) on IL-6 gene expression was
examined. After 4 h stimulation (Figure 4c), as expected,
stimulation with Pam3CSK4 and Poly (I:C) alone induced
IL-6 expression. However, by contrast to TLSP expres-
sion, addition of IL-4 and TNF-a to the culture medium did
not induce any significant upregulation of IL-6 after 4 h
Table 2. Sequences of primers used for gene expression quantification by quantitative reverse transcription (qRT)-PCR
Gene Primer Sequence (5’-3’) R2 value
TSLP Forward primer CCACAGTAGACAGTGTGGTTGAA 0.9854
Reverse primer TAGGGCTGGTGCTGACCTAC
IL-6 Forward primer TTCACAGAATGAGTGGCTGAAGA 0.9994
Reverse primer GGCTGAACTGCAGGAAATCC
UBB (ubiquitin B, housekeeping gene) Forward primer ATGTGAAGGCCAAGATCCAG 0.9836
Reverse primer AAATCTGCATCCCACCTCTTG
R2 (coefficient of determination) values range from 0 to 1, where 1 indicates a total fit of the primer and 0 indicates the lowest fit.
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stimulation. Moreover, addition of cytokine milieu to
Pam3CSK4 did not induce a significant upregulation of IL-
6 after 4 h stimulation, either. Combination of Poly (I:C)
and atopic cytokine milieu induced a significant upregula-
tion of IL-6 after 4 h stimulation, when compared to stim-
ulation induced by Poly (I:C) only, but the effect was
much weaker for IL-6 compared to TSLP expression.
Twenty-four hour stimulation with atopic cytokine milieu
significantly upregulated IL-6 gene expression. The addi-
tion of atopic inflammation cytokine milieu to Pam3CSK4
or Poly (I:C) induced a statistically significant further
upregulation of IL-6 (Figure 4d).
Discussion
The present study demonstrates that equine TSLP is sig-
nificantly upregulated in lesional skin from IBH-affected
horses when compared to healthy controls, thus indicat-
ing a potential role of this cytokine in the pathogenesis of
IBH. A study has shown that TSLP protein is highly
expressed in lesional skin of AD human patients, with no
expression in patients without skin disease, which sug-
gests that TSLP expression patterns are similar in equine
and human counterparts.4
The data herein suggested that TSLP is involved in the
pathogenesis of equine IBH, so the possible triggers of
TSLP expression were investigated. Being on the inter-
face between body and the environment, keratinocytes
are in constant contact with a plethora of bacteria and
viruses. Thus, it was hypothesized that TLR-L that corre-
spond to certain bacterial- and viral PAMPs upregulate
TSLP expression. First, primary equine keratinocytes cul-
tures were established using modified protocols.11,15
Although fibroblast contaminations can be common in
keratinocyte cultures, the protocol used herein yielded
fibroblast-free cultures, as demonstrated by immunofluo-
rescence staining of cytokeratin and vimentin.
Even though all TLR-L except TLR-L 9, induced a signifi-
cant TSLP upregulation, the strongest upregulation after
4 h was induced by Pam3CSK4, which is a synthetic tria-
cylated lipoprotein found in both Gram-positive and -nega-
tive bacteria, and ligand for TLR 1/2. Interestingly, the
strongest TSLP upregulation after 24 h stimulation was
observed with Poly (I:C), and this upregulation was much
stronger when compared to 4 h upregulation. Poly (I:C) is
a synthetic analogue of double-stranded RNA (dsRNA),
that can be recognized by TLR-3. Unlike TLR-1/2, 4 and
5, TLR-3 is an intracellular TLR, which may account for
the prolonged time needed for the Poly (I:C) to induce
TSLP and IL-6 upregulation, in comparison with ligands
stimulating TLRs expressed on the cell membrane.18 In
human keratinocytes, TSLP upregulation is induced via
TLR-L 2/6, 3 and 5, after 18 h stimulation.19–22 Interest-
ingly, Pam3CKS4 did not induce TSLP expression in
human keratinocytes.19 A possible reason for this dis-
crepancy between the effect of Pam3CSK4 on human
and equine keratinocytes might be the origin of the
reagent. Additionally, 200 ng/mL Pam3CSK4 was used,
whereas human keratinocytes were stimulated with
5 lg/mL.19 When 5 lg/mL Pam3CSK4 was used to stim-
ulate equine keratinocytes, TSLP gene expression was
upregulated as compared to nonstimulated cells, but the
upregulation was not as strong as with a lower concentra-
tion of this TLR-L, suggesting that 5 lg/mL of Pam3CSK4
might not be the optimal concentration. Human ker-
atinocytes, however, upregulated TSLP when stimulated
with FSL-1, a TLR 2/6-L.19 TLR-2 can form heterodimers
with either TLR-1 or TLR-6, and it is possible that human
keratinocytes form TLR-2/6 dimers whereas equine ker-
atinocytes form TLR-1/2 dimers, and thus upregulate
TSLP when stimulated with corresponding ligands.13
Interestingly, conversely to humans, flagellin did not
induce a strong upregulation of TSLP in equine ker-
atinocytes; however, this TLR-L induced a strong TSLP
production in equine PBMCs. How these TLR-L actually
impact skin inflammation remains to be elucidated.
In order to investigate whether TLR-L-induced TSLP
expression is indeed mediated via TLR signalling, the
expression of the pro-inflammatory cytokine IL-6 induced
via NF-jB, a downstream TLR signalling pathway effec-
tor, was examined.18,23 IL-6 was upregulated as expected
by stimulation with TLR 1-5-L, but not with TLR 7-L and 8-
L, suggesting that resiquimod induced TSLP expression
may not be mediated via TLR 7 and 8. Moreover, it is
known that some ligands, such as dsRNA (TLR-3 ligand)
also can be recognized by molecules other than TLR 3,
such as melanoma differentiation antigen 5 (MDA5), reti-
noid-inducible gene 1 (RIG-1) and IFN-inducible double
stranded RNA-activated protein kinase (PKR).24–26 There-
fore, further studies will be required to decipher the exact
mechanisms of TLR-L-induced TSLP expression in pri-
mary equine keratinocytes.
The TLR-L-induced expression patterns of TSLP and IL-
6 differed between equine keratinocytes and PBMCs. For
example, the strongest TSLP upregulation in PBMCs was
induced by flagellin, which induced only a moderate
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Figure 1. Thymic stromal lymphopoietin (TSLP) expression in lesional
skin of Insect Bite Hypersensitivity affected (n = 9) and in skin of
healthy horses (n = 9) assessed by qRT-PCR.
Statistical analysis of differences between groups was performed
using the Mann Whitney U-test. *p ≤ 0.05
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expression of this cytokine in keratinocytes. This indi-
cates that certain cell types in PBMCs express a different
set of TLRs when compared to keratinocytes and are
therefore stimulated to produce TSLP. However, it is not
known which cell types are sources of equine TSLP in
PBMCs, and this needs further investigation. Moreover,
patterns of TLR expression in equine PBMCs remain to
be elucidated. In addition, the expression profile and
activity of different TLRs in equine keratinocytes are cur-
rently unknown.
In allergic humans, TH-2 cytokines (IL-4, IL-13) and
TNF-a have been described as atopic cytokine
milieu.19,21,22 Keratinocytes can come into contact with
this milieu through interactions with TH-2 cells, basophils
or mast cells that produce these cytokines. Therefore, to
study the possible effect of atopic cytokine milieu alone
or in combination with Pam3CSK4 or Poly (I:C) on TSLP
expression, cytokines of atopic inflammatory milieu (re-
combinant equine IL-4 and TNF- a) were added to the cul-
ture medium. The milieu was combined only with
Pam3CSK4 and Poly (I:C), the TLR-L that induced a clear
TSLP upregulation in the present study. Addition of the
atopic cytokine milieu alone already induced a significant
TSLP upregulation, and when combined with Pam3CSK4
or Poly (I:C), it synergistically further upregulated TSLP
expression. In skin allergic conditions including IBH,
clinical signs are exacerbated by secondary bacterial
infections.10,27 As mentioned, Pam3CSK4 is a constituent
of bacterial membranes recognized by TLR1/2 heterodi-
mers.28 The results herein showing a strong upregulation
of TSLP expression by Pam3CSK4 and its synergistic
effects with atopic cytokine milieu, suggest that sec-
ondary bacterial infections in an allergic microenviron-
ment can amplify TH-2 inflammation via the induction of
TSLP, thus forming a vicious circle and exacerbation of
the disease. Likewise, combining Poly (I:C) with the ato-
pic cytokine milieu significantly increased TSLP gene
expression after both 4 h and 24 h stimulation, when
compared to Poly (I:C)-induced TSLP expression. Interest-
ingly, dsRNA and Poly (I:C) TLR-3 have been associated
with the mechanism for detection of skin damage and
early inflammation initiation independent of viral activa-
tion. 29 Because IBH lesions have evident skin damage
that in chronic cases can occur as epidermal necrosis, it is
speculated that dsRNA released from damaged cells can
trigger TSLP production in keratinocytes and could thus
result in exacerbation of the disease. These synergistic
effects of the atopic cytokine milieu and TLR-L on TSLP
expression also have been described in human: TLR-L
Poly (I:C), FSL-1 and flagellin-induced TSLP expression,
and, additionally, when combined with allergic inflamma-
tion cytokine milieu, these TLR-L synergistically further
a b
c d
Figure 2. Immunofluorescence staining of keratinocytes and fibroblasts.
Primary equine keratinocytes and fibroblasts were stained with anti-cytokeratin and anti-vimentin antibody. (a) Staining of primary keratinocyte cul-
tures with anti-cytokeratin: cytoplasmic cytokeratin is shown in green; nuclei were counterstained with Hoechst and are shown in blue. (b) Staining
of keratinocytes with anti-vimentin: no staining was observed with this antibody. Nuclei are shown in blue. 40x magnification. (c) Equine fibroblasts
stained with anti-vimentin: cytoplasmic vimentin is shown in green; nuclei were counterstained with Hoechst and are shown in blue. (d) Staining
of fibroblasts with anti-cytokeratin: no staining was observed with this antibody. Nuclei are shown in blue. 20x magnification
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upregulate TSLP expression. 19,21,22 Based on the data
herein, it is therefore hypothesized that stimulation of TLR
on keratinocytes by bacterial or viral PAMPs from the envi-
ronment may lead to an increased release of TSLP in
horses suffering from IgE-mediated skin allergies. This
effect may be due to the allergic cytokine microenviron-
ment in the skin of these animals, as demonstrated for IBH
and recurrent urticaria.17,30 Further studies to investigate
TSLP expression at the protein level are now required to
confirm the role of TSLP in equine skin allergy.
In conclusion, the present study strongly suggests an
important role for TSLP in the pathogenesis of IBH, as
demonstrated by increased mRNA expression in the skin
of IBH-affected horses as well as by the strong ability of
equine keratinocytes to produce TSLP in response to
TLR-L, present in the skin microenvironment and possi-
bly also in the saliva of the causative insects. Further
studies will be needed to elucidate whether the
response of keratinocytes differs solely between allergic
and nonallergic horses, or whether the observed
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Figure 3. Thymic stromal lymphopoietin (TSLP) and IL-6 gene expression in primary equine keratinocytes derived from six horses assessed by
qRT-PCR.
Cells were cultured with medium alone, PMA - phorbol 12-myristate 13-acetate (50 ng/ml) + ionomycin (1 lmol/mL), Pam3CSK4 (200 ng/ml), Poly
(I:C) (5 lg/ml), Lipopolysaccharide (LPS) (5 lg/ml), Flagellin from Salmonella Typhimurium (FLA-ST) (200 ng/ml) and resiquimod (5 lg/ml) for 4 h
and 24 h. (a) and (b) TSLP expression after 4 h and 24 h of stimulation. (c) and (d) IL-6 expression after 4 h and 24 h of stimulation Asterisk (*) indi-
cates statistically significant TSLP and IL-6 upregulation compared to non-stimulated control in the Mann Whitney U-test, after correction for multi-
ple comparisons (*cP ≤ 0.05). NS = non-stimulated control.
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increased TSLP expression is only associated with the
allergic inflammation micro-milieu present in the skin of
IBH-affected horses.
Acknowledgements
We thank Jelena Mirkovitch, Michael Stoffel, Ana Sto-
jiljkovic, Jasmin Balmer and Helga Mogel for their expert
laboratory assistance. We are grateful to Gertraud
Sch€upbach-Regula, Department for Clinical Research and
Veterinary Public Health (DCR-VPH), Veterinary Public
Health Institute, University of Bern, for assistance with
the statistical analysis. This work was supported by the
Swiss National Science Foundation grant no. 310030-
160196/1.
References
1. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic
inflammation. J Exp Med 2006; 203: 269–273.
2. Takai T. TSLP expression: cellular sources, triggers, and regula-
tory mechanisms. Allergol Int 2012; 61: 3–17.
3. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway
in the initiation of dendritic cell-mediated allergic inflammation. J
Allergy Clin Immunol 2007; 120: 238–244; quiz 245–6.
1
10
100
1,000
Pam3CSK4
Poly I:C
IL-4+TNF-
–
–
+
+
–
–
+
–
+
–
+
–
–
+
+
–
–
–
*
*
*
1
10
100
1,000
10,000
Pam3CSK4
Poly I:C
IL-4+TNF-
–
–
+
+
–
–
+
–
+
–
+
–
–
+
+
–
–
–
*
*
*
1
10
100
Pam3CSK4
Poly I:C
IL-4+TNF-
–
–
+
+
–
–
+
–
+
–
+
–
–
+
+
–
–
–
*
1
10
100
1,000
Pam3CSK4
Poly I:C
IL-4+TNF-
–
–
+
+
–
–
+
–
+
–
+
–
–
+
+
–
–
–
*
*
*
4 h
R
el
at
iv
e 
TS
LP
 m
R
N
A
 e
xp
re
ss
io
n
R
el
at
iv
e 
IL
-6
 m
R
N
A
 e
xp
re
ss
io
n
24 h
4 h 24 h
a b
c d
Figure 4. Thymic stromal lymphopoietin (TSLP) and IL-6 gene expression in primary equine keratinocytes (n = 6) assessed by qRT-PCR.
Cells were stimulated with medium alone, allergic inflammation cytokine milieu consisting of IL-4 (100 ng/ml) and TNF-a (100 ng/ml), Pam3CSK4
(200 ng/ml) and Poly (I:C) (5 lg/ml) alone or in combination with the cytokine milieu for 4 h and 24 h. (a) and (b) TSLP expression after 4 h and
24 h of stimulation. (c) and (d) IL-6 expression after 4 h and 24 h of stimulation. Asterisk (*) indicates statistically significant TSLP and IL-6 upregu-
lation in the Wilcoxon Signed-Rank test (*p< 0.05)
© 2019 The Authors. Veterinary Dermatology published by John Wiley & Sons Ltd on behalf of the ESVD and ACVD, 0, 1–11.8
Cvitas et al.
4. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells
trigger dendritic cell mediated allergic inflammation by producing
TSLP. Nat Immunol 2002; 3: 673–680.
5. Ebner S, Nguyen VA, Forstner M, et al. Thymic stromal lym-
phopoietin converts human epidermal Langerhans cells into anti-
gen-presenting cells that induce proallergic T cells. J Allergy Clin
Immunol 2007; 119: 982–990.
6. Rochman I, Watanabe N, Arima K, et al. Cutting edge: direct
action of thymic stromal lymphopoietin on activated human
CD4+ T cells. J Immunol 2007; 178: 6,720–6,724.
7. Hammad H, Lambrecht BN. Barrier Epithelial Cells and the Con-
trol of Type 2 Immunity. Immunity 2015; 43: 29–40.
8. Wong CK, Hu S, Cheung PF, et al. Thymic stromal lymphopoietin
induces chemotactic and prosurvival effects in eosinophils: impli-
cations in allergic inflammation. Am J Respir Cell Mol Biol 2010;
43: 305–315.
9. Bogiatzi SI, Fernandez I, Bichet JC, et al. Cutting Edge: Proin-
flammatory and Th2 cytokines synergize to induce thymic stro-
mal lymphopoietin production by human skin keratinocytes. J
Immunol 2007; 178: 3,373–3,377.
10. Schaffartzik A, Hamza E, Janda J, et al. Equine insect bite hyper-
sensitivity: what do we know? Vet Immunol Immunopathol
2012; 147: 113–126.
11. Janda J, Plattet P, Torsteinsdottir S, et al. Generation of equine
TSLP-specific antibodies and their use for detection of TSLP pro-
duced by equine keratinocytes and leukocytes. Vet Immunol
Immunopathol 2012; 147: 180–186.
12. Klukowska-Rotzler J, Marti E, Lavoie JP, et al. Expression of thy-
mic stromal lymphopoietin in equine recurrent airway obstruc-
tion. Vet Immunol Immunopathol 2012; 146: 46–52.
13. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev
Immunol 2001; 1: 135–145.
14. Leise BS, Yin C, Pettigrew A, et al. Proinflammatory cytokine
responses of cultured equine keratinocytes to bacterial patho-
gen-associated molecular pattern motifs. Equine Vet J 2010; 42:
294–303.
15. Dahm AM, de Bruin A, Linat A, et al. Cultivation and characterisa-
tion of primary and subcultured equine keratinocytes. Equine
Vet J 2002; 34: 114–120.
16. Hamza E, Doherr MG, Bertoni G, et al. Modulation of allergy inci-
dence in icelandic horses is associated with a change in IL-4-pro-
ducing T cells. Int Arch Allergy Immunol 2007; 144: 325–337.
17. Hinden S, Klukowska-Rotzler J, Janda J, et al. Characterization
of the inflammatory infiltrate and cytokine expression in the skin
of horses with recurrent urticaria. Vet Dermatol 2012; 23: 503–
e99.
18. Jimenez-Dalmaroni MJ, Gerswhin ME, Adamopoulos IE. The
critical role of toll-like receptors–From microbial recognition to
autoimmunity: A comprehensive review. Autoimmun Rev 2016;
15: 1–8.
19. Vu AT, Baba T, Chen X, et al. Staphylococcus aureus membrane
and diacylated lipopeptide induce thymic stromal lymphopoietin
in keratinocytes through the Toll-like receptor 2-Toll-like receptor
6 pathway. J Allergy Clin Immunol 2010; 126: 985–993.e3.
20. Vu AT, Chen X, Xie Y, et al. Extracellular double-stranded RNA
induces TSLP via an endosomal acidification- and NF-kappaB-de-
pendent pathway in human keratinocytes. J Invest Dermatol
2011; 131: 2,205–2,212.
21. Xie Y, Takai T, Chen X, et al. Long TSLP transcript expression
and release of TSLP induced by TLR ligands and cytokines in
human keratinocytes. J Dermatol Sci 2012; 66: 233–237.
22. Le TA, Takai T, Vu AT, et al. Flagellin induces the expression of
thymic stromal lymphopoietin in human keratinocytes via toll-like
receptor 5. Int Arch Allergy Immunol 2011; 155: 31–37.
23. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front
Immunol 2014; 5: 461.
24. Matsumoto M, Seya T. TLR3: interferon induction by double-
stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008; 60:
805–812.
25. McAllister CS, Samuel CE. The RNA-activated protein kinase
enhances the induction of interferon-beta and apoptosis medi-
ated by cytoplasmic RNA sensors. J Biol Chem 2009; 284:
1,644–1,651.
26. Takeuchi O, Akira O. Pattern recognition receptors and inflam-
mation. Cell 2010; 140: 805–820.
27. Fettelschoss-Gabriel A, Fettelschoss V, Thoms F, et al. Treating
insect-bite hypersensitivity in horses with active vaccination
against IL-5. J Allergy Clin Immunol 2018; 142: 1,194–1,205.e3.
28. Schenk M, Belisle JT, Modlin RL. TLR2 looks at lipoproteins.
Immunity 2009; 31: 847–849.
29. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regu-
late Toll-like receptor 3-dependent inflammation after skin injury.
Nat Med 2009; 15: 1,377–1,382.
30. Heimann M, Janda J, Sigurdardottir OG, et al. Skin-infiltrating T
cells and cytokine expression in Icelandic horses affected with
insect bite hypersensitivity: a possible role for regulatory T cells.
Vet Immunol Immunopathol 2011; 140: 63–74.
Supporting Information
Additional Supporting Information may be found in the
online version of this article.
Figure S1. Thymic stromal lymphopoietin (TSLP) (a-b)
and IL-6 (c-d) gene expression in peripheral blood
mononuclear cells (PBMCs) isolated from three horses,
assessed by qRT-PCR.
Table S1a.Median Thymic stromal lymphopoietin (TSLP)
mRNA expression (presented as Log 2 DDCT) in ker-
atinocytes stimulated with PMA-Ionomycin as positive
control and various Toll like receptor-Ligands in compar-
ison to non-stimulated cells for 4 and 24 hours.
Table S1b. Median IL-6 mRNA expression (presented as
Log 2 DDCT) in keratinocytes stimulated with PMA-Iono-
mycin as positive control and various Toll like receptor -
Ligands in comparison to non-stimulated cells for 4 and
24 hours.
Table S1c. Effect of a combination of IL-4 and TNF- a on
TSLP expression.
Table S1d. Effect of a combination of IL-4 and TNF-a on
IL-6 expression.
Resume
Contexte – Le TSLP (Thymic stromal lymphopoietin) joue un ro^le cle dans le developpement de
l’inflammation allergique. On en sait peu sur les facteurs possibles d’expression de TSLP chez le cheval.
Hypotheses/objectifs – Etudier l’expression de TSLP dans les lesions cutanees de l’hypersensibilite aux
piqures d’insectes (IBH) chez le cheval. La capacite des ligands TLR 1-8 (L) et des cytokines atopiques
comme declencheurs potentiels de TSLP et d’interleukine (IL)-6 comme molecule effectrice de regulation
du signal TLR, ont ete examines dans des cultures de keratinocytes equins primaires.
Sujets – La peau lesionnelle d’IBH atteints et de peau saine de chevaux contro^les (n=9 pour chaque
groupe) a ete prelevee.
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Materiel et methodes – Les cultures de keratinocytes ont ete realisees a partir de six chevaux sains et sti-
mules par TLR 1-8-L, et avec IL-4 et TNF-a, pour mimer une inflammation atopique. L’expression des genes
de TSLP et IL-6 a ete determinee par PCR quantitative en temps reel.
Resultats – L’expression de TSLP est significativement plus elevee dans les lesions d’IBH compare a la
peau saine. Les TLR 1-8-L ont significativement augmente l’expression de TSLP dans les keratinocytes.
L’augmentation de regulation la plus marquee etait induite par TLR 1/2-L et TLR 3-L. La combinaison de
milieu de cytokine atopique et TLR 1/2-L ou TLR 3-L augmente davantage l’expression de TSLP. La stimula-
tion de TLR 1-5 a significativement augmente l’expression d’IL-6.
Conclusion et importance clinique – Les donnees ci dessus suggerent que l’augmentation de regulation
de l’expression de TSLP dans les lesions cutanees de chevaux atteints d’IBH pourrait jouer un ro^le dans le
developpement d’IBH. En outre, l’expression de TSLP est induite par TLR-L, en particulier par TLR 1/2-L et
TLR 3-L, et est d’autant plus augmente que le milieu de cytokine atopique, indiquant un mecanisme
d’exacerbation d’IBH medie par TSLP.
Resumen
Introduccion – la linfopoyetina del estroma tımico (TSLP) desempe~na un papel clave en el desarrollo de la
inflamacion alergica. Poco se sabe sobre posibles desencadenantes de expresion de TSLP equina.
Hipotesis/objetivos – investigar la expresion de TSLP en lesiones cutaneas de hipersensibilidad por pica-
dura de insecto en equinos (IBH). Se examinaron la capacidad de los ligandos TLR 1-8 (L) y del medio de
citoquinas en atopia como posibles desencadenantes de TSLP y de interleuquina (IL) -6 como una molecula
efectora posterior a la se~nal estimulante de TLR en cultivos primarios de queratinocitos equinos.
Animales – se tomaron muestras de piel lesionada de caballos con IBH y de piel sana de caballos control
(n = 9 cada grupo).
Metodos y materiales – se establecieron cultivos de queratinocitos a partir de seis caballos sanos y se
estimularon con TLR 1-8-L, y con IL-4 y factor de necrosis tumoral-a, para imitar un medio de citoquinas en
inflamacion en atopia. La expresion del gen TSLP e IL-6 se evaluaron por PCR cuantitativa en tiempo real.
Resultados – la expresion de TSLP fue significativamente mayor en los queratinocitos de lesiones de IBH
en comparacion con los de la piel sana. TLR 1-8-L aumento significativamente la expresion de TSLP en que-
ratinocitos. La regulacion positiva mas fuerte fue inducida por TLR 1/2-L y TLR 3-L. La combinacion del
medio de citoquinas en atopia y TLR 1/2-L o TLR 3-L aumento aun mas la expresion de TSLP. La estimu-
lacion de TLRL 1-5 aumento significativamente la expresion de IL-6.
Conclusiones e importancia clınica – los datos en este documento sugieren que la regulacion positiva de
la expresion de TSLP en la piel lesionada de los caballos afectados por IBH podrıa desempe~nar un papel en
el desarrollo de IBH. Ademas, la expresion de TSLP es inducida por TLR-L, en particular por TLR 1/2-L y
TLR 3-L, y aumenta aun mas por medio de citoquinas en atopia, lo que indica un mecanismo para la exacer-
bacion de signos clınicos de IBH mediada por TSLP.
Zusammenfassung
Hintergrund – Das Thymic Stromal Lymphopoietin (TSLP) spielt eine Schl€usselrolle bei der Entwicklung
allergischer Entz€undung. Es ist wenig bekannt €uber die m€oglichen Ausl€oser der Exprimierung des equinen
TSLP.
Hypothese/Ziele – Das Ziel war eine Untersuchung der TSLP Exprimierung in Hautver€anderungen bei der
Insektenstich Hypersensibilit€at des Pferdes (IBH). Die F€ahigkeit von TLR 1-8 Liganden (L) und des atopi-
schen Zytokinmilieus als m€ogliche Ausl€oser von TSLP und von Interleukin (IL)-6 als Downstream Effektor
Molek€ul f€ur die TLR Signalgebung wurden in prim€aren Keratinozytenkulturen von Pferden untersucht.
Tiere – Es wurden L€asionen der Haut von Pferden mit IBH und gesunder Haut von Kontrollpferden (n = 9 in
jeder Gruppe) untersucht.
Methoden und Materialien – Es wurden Keratinozytenkulturen von sechs gesunden Pferden hergestellt
und mit TLR 1-8-L, mit IL-4 und Tumor Nekrose Faktor-a stimuliert, um das Zytokinmilieu einer atopischen
Entz€undung zu imitieren. Die TSLP und IL-6 Genexprimierung wurde mittels quantitativem Real-Time PCR
untersucht.
Ergebnisse – Die Exprimierung von TSLP war in IBH L€asionen im Vergleich zur gesunden Haut signifikant
h€oher. TLR 1-8-L erh€ohte die TSLP Exprimierung in den Keratinozyten signifikant. Die st€arkste Erh€ohung
wurde von TLR 1/2-L und TLR 3-L induziert. Eine Kombination des atopischen Zytokinmilieus und TLR 1/2-L
oder TLR 3-L erh€ohte die TSLP Exprimierung noch deutlicher. Die TLRL 1-5 Stimulierung erh€ohte die IL-6
Exprimierung signifikant.
Schlussfolgerungen und klinische Bedeutung – Diese Ergebnisse weisen darauf hin, dass die Erh€ohung
einer TSLP Exprimierung in l€asionaler Haut bei IBH-betroffenen Pferden eine Rolle bei der Entwicklung der
IBH spielen k€onnte. Dar€uber hinaus wird die TSLP Exprimierung durch TLR-L induziert, vor allem durch TLR
1/2-L und TLR 3-L und wird durch ein atopisches Zytokinmilieu weiter erh€oht, was auf den Mechanismus
einer TSLP-vermittelten Verschlimmerung der IBH hinweist.
Cvitas et al.
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要約
背景 – 胸腺間質性リンパ球新生因子(TSLP)は、アレルギー性炎症の発症に重要な役割を果たす。馬の
TSLP発現のトリガーの可能性についてはほとんど知られていない。
仮説/目的 – 本研究の目的は、馬の昆虫刺咬性過敏症(IBH)の皮膚病変におけるTSLP発現を調査すること
である。 TLRシグナル伝達の下流エフェクター分子としてのTSLPおよびインターロイキン(IL)-6の潜在
的トリガーとしてのTLR 1-8リガンド(L)およびアトピー性サイトカイン環境の能力を、一次馬ケラチノサ
イト培養で調査された。
被験動物 – IBHに罹患した馬の病変皮膚および対照馬の健常皮膚(n = 9各グループ)をサンプリングした。
材料と方法 – ケラチン生成細胞培養を、6頭の健常馬によって確立し、TLR 1-8-L、IL-4および腫瘍壊死因
子-aで刺激し、アトピー性炎症サイトカイン環境を模倣した。 TSLPおよびIL-6遺伝子発現を、定量リア
ルタイムPCRにより評価した。
結果 – TSLP発現は、健常皮膚と比較してIBH病変において有意に多かった。 TLR 1-8-Lは、ケラチン生成
細胞におけるTSLP発現を有意に上方制御した。最も強いアップレギュレーションは、TLR 1 / 2-Lおよび
TLR 3-Lによって誘導された。アトピー性サイトカイン環境およびTLR 1 / 2-LまたはTLR 3-Lの組み合わ
せは、TSLP発現をさらに増加させた。 TLRL 1-5刺激は、IL-6発現を有意にアップレギュレートした。
結論と臨床的重要性 –本データは、IBHに罹患した馬の病変皮膚におけるTSLP発現の上方制御がIBHの発
生に役割を果たす可能性があることを示唆している。さらに、TSLP発現は、TLR-L、特にTLR 1 / 2-Lお
よびTLR 3-Lによって誘導され、アトピー性サイトカイン環境によってさらに増加し、TSLPを介したIBH
の増悪メカニズムを示している。
摘要
背景 – 胸腺基质淋巴生成素(TSLP)在过敏性炎症发生过程中起关键作用。目前对马的TSLP表达的可能触发
因素知之甚少。
假设/目的 – 研究TSLP在马昆虫叮咬超敏反应(IBH)皮肤病变中的表达。在初代马角质细胞培养基中,研究
TLR1-8配体(L)和异位性细胞因子环境作为TSLP的潜在触发因子,以及白介素(IL)-6作为TLR信号下游效应分
子的能力。
动物 – 采集IBH的病变皮肤和对照组马的健康皮肤(每组9例)作为样本。
方法和材料 – 从六匹健康马身上制备角质细胞培养基,给予TLR1-8-L、IL-4和肿瘤坏死因子-a刺激,模仿异
位性炎症细胞因子环境。实时荧光定量PCR检测TSLP和IL-6基因表达。
结果 – 与健康皮肤相比,TSLP在IBH病变中的表达明显增加。TLR1-8-L显著上调TSLP在角质细胞中的表
达。其中TLR1/2-L和TLR3-L诱导上调最强。异位性细胞因子环境与TLR1/2-L或TLR3-L联合进一步增加
了TSLP的表达。TLRL1-5刺激显著上调IL-6的表达。
结论和临床意义 –本文数据表明,IBH患马病变皮肤中的TSLP表达上调,可能在IBH的发生过程中发挥作用。
此外,TSLP的表达由TLR-l诱导,尤其是TLR1/2-L和TLR 3-L,并在异位性细胞因子环境中进一步增加,提示
TSLP介导IBH加重的机制。
Resumo
Contexto – A linfopoietina estromal tımica (TSLP) desempenha um papel fundamental no desenvolvi-
mento da inflamac~ao alergica. Pouco se sabe sobre possıveis gatilhos da express~ao de TSLP em equinos.
Hipotese/objetivos – Investigar a express~ao de TSLP em les~oes cuta^neas de hipersensibilidade a picada
de inseto (IBH) em equinos. A capacidade dos ligantes TLR 1-8 (L) e do meio de citocinas atopicas como
potenciais gatilhos da TSLP e da interleucina (IL) -6 como uma molecula efetora a jusante da sinalizac~ao de
TLR, foram examinados em culturas primarias de queratinocitos equinos.
Animais – Coletou-se a amostras de pele lesional de equinos afetados por IBH e a pele saudavel de cava-
los controle (n = 9 cada grupo).
Metodos e materiais – Culturas de queratinocitos foram iniciadas a partir de material de seis equinos
saudaveis e estimuladas com TLR 1-8-L, IL-4 e com fator de necrose tumoral-a, para imitar um meio de
citocina de inflamac~ao atopica. A express~ao do gene TSLP e IL-6 foi avaliada por PCR quantitativo em
tempo real.
Resultados – A express~ao de TSLP foi significativamente maior nas les~oes de IBH em comparac~ao com a
pele saudavel. TLR 1-8-L aumentou positivamente a express~ao de TSLP nos queratinocitos. Maior reg-
ulac~ao positiva foi induzida por TLR 1/2-L e TLR 3-L. A combinac~ao do meio de citocinas atopicas e TLR 1/2-
L ou TLR 3-L aumentou ainda mais a express~ao de TSLP. A estimulac~ao com TLRL 1-5 aumentou significa-
tivamente a express~ao de IL-6.
Conclus~oes e importa^ncia clınica – Os dados do presente estudo sugerem que a regulac~ao positiva da
express~ao de TSLP na pele lesional de cavalos afetados por IBH pode desempenhar um papel no desenvol-
vimento da IBH. Alem disso, a express~ao de TSLP e induzida por TLR-L, em particular por TLR 1/2-L e TLR
3-L, e e ainda aumentada pelo meio de citocinas atopicas, indicando um mecanismo para a exacerbac~ao da
IBH mediada por TSLP.
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